In a Finnish nationwide diabetic study, the use of metformin, other oral antidiabetic medications, and statins was not associated with breast cancer, but a slightly increased risk of breast cancer was observed among insulin users (HR 1.18, 95% CI 1.03–1.36)28, which was similar to other studies conducted in Taiwan32,33. Here, INS is linked to breast carcinoma.